| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230259A1 S-allylmercaptoglutathione and uses thereof |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230230A1 Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229927A1 Use of a growth hormone or a growth hormone secretagogue for appetite-suppression or induction of satiety |
| 08/14/2002 | EP1229919A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 08/14/2002 | EP1229918A2 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 08/14/2002 | EP1229895A1 Slimming composition containing a substance inducing il-6 production |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/14/2002 | DE10105308A1 Sorbinsäure als wachstumsstabilisierender Zusatz zu Futtermitteln für die Nutztieraufzucht Sorbic acid as an additive to wachstumsstabilisierender feed for livestock production |
| 08/14/2002 | CN1364168A Hydrochloride of fused-heterocycle compound |
| 08/14/2002 | CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors |
| 08/14/2002 | CN1364166A Polymorphic salt as medicine for migraine |
| 08/14/2002 | CN1364157A N-(indolcarbonyl) piperazin derivatives |
| 08/14/2002 | CN1364156A Novel naphthalene ureas as glucose uptake enhancers |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364153A Substituted phenoxyacetic acids |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1364077A Multilayer pharmaceutical product for release in the colon |
| 08/14/2002 | CN1363611A Extracting process and application of polygonapolyose |
| 08/14/2002 | CN1363559A Insulinotropic hormone secretion peptide derivative |
| 08/14/2002 | CN1363373A Chinese medicine for treating hyperliponia and fatty liver |
| 08/14/2002 | CN1363367A Active components of Chinese-medicinal medicine with weight-losing and hypolipemic actions and its relative medicine |
| 08/14/2002 | CN1363363A Grape seed preparation and its extracting process |
| 08/14/2002 | CN1363355A Process for preparing hypolipemic giant knotweed rhizome tablet |
| 08/14/2002 | CN1363334A Nano medicine 'Dabuyin' and its preparing process |
| 08/14/2002 | CN1363308A Nano medicine 'Jisheng Shenqi' and its preparing process |
| 08/14/2002 | CN1363288A Nano medicine for eliminating thrombus and its preparing process |
| 08/14/2002 | CN1363282A Multifunctional 'Baikuang Kangti Powder' |
| 08/14/2002 | CN1363274A Application of ligustrazine and aminoguanidin in treating II-type diabetes and its complication |
| 08/14/2002 | CN1363273A Medicine for treating vascular endotheliocyte disfunction type cardiovascular disease |
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
| 08/13/2002 | US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 08/13/2002 | US6433026 Process for removing bile salts from a patient and alkylated compositions therefor |
| 08/13/2002 | US6433015 Administering a given dosage of creatine |
| 08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432993 Substituted fused heterocyclic compound |
| 08/13/2002 | US6432984 Cannabinoid receptor antagonists; treatment of obesity, drug addiction, alcholism, psychological, and eating disorders |
| 08/13/2002 | US6432982 Benzothiophenes, and formulations and methods using same |
| 08/13/2002 | US6432960 Anorexogenic agents to promote weight loss and treat eating disorders |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432929 Cartilage enhancing food supplements and methods of preparing the same |
| 08/13/2002 | US6432684 Human nucleotide sequence encode a polypeptide for denaturing polyunsaturated fatty acid |
| 08/13/2002 | US6432449 Anionic polysaccharides coupled with a metal and a complex leptin protein; biocompatible injections having no side effects |
| 08/13/2002 | US6432447 Core of fluvastatin, hydroxypropyl methyl cellulose and optionally other excipients, dosage form is color-stable during storage |
| 08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
| 08/13/2002 | CA2111447C Hypoglycemic thiazolidinediones and intermediates |
| 08/13/2002 | CA2088994C Therapeutically active mixture of glutathion and anthocyan compounds |
| 08/13/2002 | CA2063938C Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis |
| 08/13/2002 | CA1341382C Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060885A1 Chemical compounds |
| 08/08/2002 | WO2002060876A1 Triaryl compounds and utilization thereof |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | WO2002060478A1 Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
| 08/08/2002 | WO2002060472A1 Remedies for hyponutrition status |
| 08/08/2002 | WO2002060466A2 Gssp3 polynucleotides and polypeptides and uses thereof |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060451A1 Method of treating certain eye diseases |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060432A1 Hypoglycemic agent |
| 08/08/2002 | WO2002060429A1 Preservation of body protein |
| 08/08/2002 | WO2002060423A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 08/08/2002 | WO2002060422A2 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | WO2002060419A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 08/08/2002 | WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060272A1 Anticholesterolemic edible oil |
| 08/08/2002 | WO2002040505A3 Dibenzoxazepine alpha v integrin receptor antagonist |